Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC is a leading global pharmaceutical company primarily focused on manufacturing and marketing generic and in-licensed pharmaceutical products. Established in 1978, Hikma operates in several key regions, including the Middle East and North Africa (MENA), Europe, and the United States, leveraging its robust manufacturing capabilities and broad distribution network. The company's extensive portfolio encompasses a range of therapeutic areas, with a particular emphasis on injectables, oral generics, and branded products. Hikma’s injectables segment serves critical healthcare needs, particularly in hospital settings, while its oral generics are vital for addressing various conditions in outpatient markets. Known for its commitment to quality and innovation, Hikma plays a crucial role in providing accessible medications globally. Importantly, it contributes to improving healthcare outcomes, reflecting its mission to put better health within reach, every day. Hikma’s strategic approach and diverse product offerings make it a significant player in the global pharmaceuticals landscape, addressing both urgent medical needs and long-term healthcare challenges.